Othera Pharmaceuticals
Conshohocken, Pennsylvania, United States
About Othera Pharmaceuticals
Othera Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases. Its products include OT-551 for geographic atrophy/dry age-related macular degeneration; OT-730 a small molecule oculoselective beta-blocker for reducing the elevated intraocular pressure associated with glaucoma; and OT-440, a neuroprotectant for glaucoma. The company was founded in 2002 and is headquartered in Exton, Pennsylvania.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.6M
- Funding stage: M&A
- Last round: Debt Financing (Aug 2009)
- Website: othera.com
- Phone: +1 484-879-2800
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/othera-pharmaceuticals-2562389 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.